Home News An Interregional Multidisciplinary Team Meeting Dedicated to Rare Breast Tumors

An interregional multidisciplinary team meeting focused on rare breast tumors

Nov. 6, 2026

Search
An interregional multidisciplinary team meeting focused on rare breast tumors
Support us Support us Healthcare professionals Pro Directory Directory Appointment Appointment Access to the Center Access

The Center Baclesse is hosting a new interregional multidisciplinary consultation meeting (RCP) focused on rare breast tumors. Held every two weeks, the meeting brings together several institutions from Normandy and Hauts-de-France to promote the sharing of expertise and adapt treatment strategies to these specific forms of cancer. 

What is a multidisciplinary team meeting (MDT)?

A multidisciplinary team meeting (MDT) brings together several specialists who review a cancer patient’s medical records together to propose a treatment strategy tailored to the patient’s situation. These discussions allow for the integration of medical expertise and the coordination of treatment decisions.

Breast cancers with specific characteristics 

Breast cancers are not a single disease. They encompass various types of tumors, which differ primarily in their cellular origin and their microscopic characteristics. 

Among them, certain histological types are rare. According to data provided by Dr. George EMILE, coordinator of the RCP, rare subtypes collectively account for about 10% of invasive breast cancers. Taken individually, each of these subtypes remains uncommon. 

This rarity poses several challenges. Scientific knowledge is sometimes limited, and rare tumors are underrepresented in clinical trials and research studies. As a result, treatment strategies are often developed based on the data available for more common forms of breast cancer. 

However, the characteristics of certain rare tumors may require a different approach. It is therefore essential to be able to bring together medical expertise and discuss each case in order to determine the most appropriate treatment strategy. 

Coordination among several healthcare facilities 

To address this challenge, an interregional multidisciplinary team (MDT) dedicated specifically to rare breast tumors has been established. It is the first organization of its kind in France. 

It currently brings together several cancer treatment centers (CLCC) and university hospitals (CHU) in Normandy and the Hauts-de-France region: 

  • the Baclesse Center in Caen; 
  • the Henri-Becquerel Center in Rouen; 
  • the Oscar Lambret Center in Lille; 
  • the Caen University Hospital; 
  • Amiens University Hospital. 

Dr. George EMILE

The RCP is also open to other healthcare facilities in these two regions, including hospitals and clinics, which may request this consultation for relevant situations. 

Coordinated by Dr. George EMILE and hosted at the Baclesse Center, this meeting is held via videoconference every two weeks, on the first and third Fridays of the month. It allows medical teams to present the cases of affected patients, compare their findings, and share their expertise. 

Pooling expertise to tailor care

By bringing together professionals from various institutions to discuss rare cases, this multidisciplinary team meeting aims to foster collective thinking and improve the appropriateness of treatment decisions. 

In particular, collaborative care ensures that the strategies typically used for the most common forms of cancer are not automatically applied to rare tumors. It promotes a personalized medicine approach that takes into account the characteristics of each tumor and the individual circumstances of each patient in order to provide tailored care. 

This initiative is part of a growing trend. Ultimately, the RCP could incorporate an epidemiological component, including the creation of a registry to better identify and characterize these tumors. A translational research component is also being considered to further their molecular characterization and advance our understanding of these rare forms of breast cancer. 

By hosting and coordinating this new interregional multidisciplinary team, the Baclesse Center is helping to develop shared expertise to benefit patients with rare breast tumors. 

Publication date :
Date of last update :
A Look Back at the IGCS International Conference  Contents NOVEMBER PERLE: Lung Cancer—Better Prevention, Screening, and Support 
Generic filters